Evaluation of cytokines and soluble adhesion molecules in patients with newly diagnosed acute myeloid leukemia: the role of TNF-alpha and FLT3-ITD

Abstract

Objectives. Acute myeloid leukemia (AML) cells are highly resistant to therapy. The presumed molecular basis of this resistance is the effect of tumor necrosis factor alpha (TNF-α) and other cytokines on endothelial adhesion molecule expression. The aim of this study was to test the hypothesis that cytokines and soluble adhesion molecules correlate in AML. Methods. Baseline serum levels of 17 cytokines and 5 soluble adhesion molecules were measured in 53 AML patients using biochip array technology. Age, leukocyte count, secondary AML, CRP, FLT3-ITD and remission were variables. Statistical analysis was performed in R version 3.1.2. Results. VCAM-1 correlated with ICAM-1 (P < 0.0001), E-selectin (P < 0.0001), leukocyte count (P = 0.0005) and TNF-α (P = 0.0035). E-selectin correlated with leukocyte count (P < 0.0001), P-selectin (P = 0.0032) and MCP-1 (P = 0.0119). CRP correlated with IL-6 (P < 0.0001), leukocyte count negatively correlated with IL-7 (P = 0.0318). FLT3-ITD was associated with higher E-selectin (P = 0.0010) and lower IL-7 (P = 0.0252). Secondary AML patients were older. Failure of induction therapy was associated with significantly higher CRP and lower P-selectin. Leukocyte count (P < 0.0001), FLT3-ITD (P = 0.0017) and secondary AML (P = 0.0439) influenced the principal component. Conclusions. Leukemic cells can modulate the microenvironment. Cytokine, adhesion molecule levels and leukocyte count correlate in AML. Understanding these mechanisms may form the basis of novel therapeutic approaches.

Effect of Monoammonium Glycyrrhizinate on the Development of Hepatotoxicity After Initial Intrathecal Chemotherapy for Leukemia

“…Previous reports have suggested that oxidative stress and elevation of proinflammatory cytokines contribute to the pathogenesis of MTX-induced liver injury (25,26). Given that the intensity of therapy is higher in induction than in maintenance therapy and that an association between proinflammatory cytokines and acute leukemia has been suggested (27,28), patients with leukemia may be at higher risk of hepatotoxicity at the beginning of induction therapy. Since there is limited information on the prevention of chemotherapy-related hepatotoxicity during the early treatment course in patients with leukemia (29), the clinical significance of hepatotoxicity and its prophylaxis in this period should be clarified.…”

Chemobrain in blood cancers: How chemotherapeutics interfere with the brain's structure and functionality, immune system, and metabolic functions

“…Experimentally, cytokines in the leukemia microenvironment enhance endothelial cells' growth 40 . Endothelial cell activation by TNF‐α was followed by concomitant induction of expression of integrins and/or selectins: VCAM‐1, ICAM‐1, and E‐selectin expression, and time‐dependent increase in the number of myeloblasts attached to the endothelium.…”

“…Experimentally, cytokines in the leukemia microenvironment enhance endothelial cells' growth. 40 Endothelial cell activation by TNF-α was followed by concomitant induction of expression of integrins and/or selectins:…”

Leukemia Stem Cell Release From the Stem Cell Niche to Treat Acute Myeloid Leukemia

“…Soluble E-selectin (sCD62E), together with sVCAM-1, are increased in serum of newly diagnosed AML patients, suggesting endothelial activation in AML ( Kupsa et al, 2016 , 2017 ). Conversely, AML blasts and LSC express E-selectin ligands, including PSGL-1, cutaneous lymphocyte antigen (CLA) and CD44 ( Kappelmayer et al, 2001 ; Chien et al, 2013 ).…”